Share Buyback Plan Authorized by Collegium Pharmaceutical (NASDAQ:COLL)
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) declared that its board has approved a stock repurchase program on Monday, July 7th, RTT News reports. The company plans to buyback $150.00 million in shares. This buyback authorization permits the specialty pharmaceutical company to repurchase up to 15.4% of its shares through open market purchases. Shares buyback […]
More Stories
Top 10 Six Sigma Tools That Will Grow Your Business in 2026
Every company faces the same problems while running its business: repeated mistakes, hidden waste, and insufficient processes that don’t deliver...
Ukraine Reports Crash of One of Its F-16s, Pilot Safe
By Victoria Friedman The Armed Forces of Ukraine said one of its F-16 fighter jets had crashed, and that the...
US Gas Prices Remain Elevated Amid Ongoing Middle East Tensions US Gas Prices Remain Elevated Amid Ongoing Middle East Tensions
By Naveen Athrappully Gasoline prices in the United States continue to remain high at over $4 per gallon as the...
Spain’s Ceuta Overwhelmed as Nearly 60,000 Illegal Immigrants Cross From Morocco in a Day
By Owen Evans Ceuta was overwhelmed overnight as the Spanish North African exclave faced a fresh wave of nearly 60,000...
Spain’s Mass Illegal Immigration Crisis: What to Know
By Troy Myers Tens of thousands of illegal immigrants crossed from Morocco into Spain in a single day, igniting worldwide...
Weekly Unemployment Claims Remain at Historically Low Levels
By Andrew Moran The number of Americans applying for unemployment benefits remained at historically low levels last week, as layoffs...